NO178882C - Fremgangsmåte for separasjon av vitamin K-avhengige blodkoagulerende faktorer - Google Patents

Fremgangsmåte for separasjon av vitamin K-avhengige blodkoagulerende faktorer

Info

Publication number
NO178882C
NO178882C NO902757A NO902757A NO178882C NO 178882 C NO178882 C NO 178882C NO 902757 A NO902757 A NO 902757A NO 902757 A NO902757 A NO 902757A NO 178882 C NO178882 C NO 178882C
Authority
NO
Norway
Prior art keywords
vitamin
separation
dependent blood
factors
blood coagulant
Prior art date
Application number
NO902757A
Other languages
English (en)
Other versions
NO178882B (no
NO902757L (no
NO902757D0 (no
Inventor
Peter Anthony Feldman
Original Assignee
Nat Blood Authority
Central Blood Lab Authority
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Blood Authority, Central Blood Lab Authority filed Critical Nat Blood Authority
Publication of NO902757L publication Critical patent/NO902757L/no
Publication of NO902757D0 publication Critical patent/NO902757D0/no
Publication of NO178882B publication Critical patent/NO178882B/no
Publication of NO178882C publication Critical patent/NO178882C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/647—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Cooling, Air Intake And Gas Exhaust, And Fuel Tank Arrangements In Propulsion Units (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • External Artificial Organs (AREA)
NO902757A 1987-12-22 1990-06-21 Fremgangsmåte for separasjon av vitamin K-avhengige blodkoagulerende faktorer NO178882C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878729822A GB8729822D0 (en) 1987-12-22 1987-12-22 Chemical process
PCT/GB1988/001150 WO1989005650A2 (en) 1987-12-22 1988-12-22 Chemical process

Publications (4)

Publication Number Publication Date
NO902757L NO902757L (no) 1990-06-21
NO902757D0 NO902757D0 (no) 1990-06-21
NO178882B NO178882B (no) 1996-03-18
NO178882C true NO178882C (no) 1996-06-26

Family

ID=10628844

Family Applications (1)

Application Number Title Priority Date Filing Date
NO902757A NO178882C (no) 1987-12-22 1990-06-21 Fremgangsmåte for separasjon av vitamin K-avhengige blodkoagulerende faktorer

Country Status (9)

Country Link
EP (1) EP0391974B1 (no)
JP (1) JPH0664B2 (no)
AT (1) ATE90567T1 (no)
AU (1) AU627446B2 (no)
DE (1) DE3881895T2 (no)
DK (1) DK175514B1 (no)
GB (1) GB8729822D0 (no)
NO (1) NO178882C (no)
WO (1) WO1989005650A2 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT402262B (de) * 1991-06-20 1997-03-25 Immuno Ag Arzneimittel enthaltend aktiviertes protein c
IT1262899B (it) * 1992-03-27 1996-07-22 Sclavo Spa Processo per l'isolamento di fattore ix, fattore x e fattore ii altamente purificati dal complesso protrombinico o dal plasma umano
DE4430204A1 (de) * 1994-08-26 1996-02-29 Behringwerke Ag Arzneimittel, welches als Gegenmittel für Blut-Antikoagulanzien geeignet ist und seine Verwendung
US5589571A (en) * 1994-10-28 1996-12-31 Cor Therapeutics, Inc. Process for production of inhibited forms of activated blood factors
US5714583A (en) 1995-06-07 1998-02-03 Genetics Institute, Inc. Factor IX purification methods
AT409334B (de) * 1997-09-19 2002-07-25 Immuno Ag Pharmazeutisches präparat enthaltend vitamin k-abhängige einzelfaktoren
SE0203551D0 (sv) * 2002-12-02 2002-12-02 Biovitrum Ab Prothrombin purification
US20060068454A1 (en) * 2004-09-27 2006-03-30 Sysmex Corporation Method of inactivating blood coagulation factor and blood coagulation factor-inactivated sample
GB0710321D0 (en) * 2007-05-30 2007-07-11 Nhs Blood & Transplant Method
US9956272B2 (en) 2007-05-30 2018-05-01 Bio Products Laboratory Limited Methods for preparing factor X, activated factor X, inactivated factor X and inactivated factor Xa, and pharmaceutical compositions comprising same
US20140206844A1 (en) 2013-01-18 2014-07-24 Prothera Biologics Methods for isolating blood products from an inter-alpha inhibitor protein-depleted blood product material
CN104328036B (zh) * 2014-10-28 2016-08-24 成都英德生物医药装备技术有限公司 一种人凝血酶原复合物吸附分离装置

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2303466C2 (de) * 1973-01-25 1975-03-20 Stanislaus Dipl.-Ing. 7340 Geislingen Malik Verfahren zur Herstellung eines Wabenträgers
JPS5263835A (en) * 1975-11-21 1977-05-26 Hokusan Kk Method of fabricating light shaped steel material
US4473553A (en) * 1983-12-02 1984-09-25 Miles Laboratories, Inc. Process for producing a lipoprotein-poor concentrate of coagulation factors VII and VIIa
FR2632309B1 (fr) * 1988-06-07 1990-08-24 Lille Transfusion Sanguine Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus
US4981952A (en) * 1988-10-04 1991-01-01 Eli Lilly And Company Method for the purification of vitamin K-dependent proteins

Also Published As

Publication number Publication date
AU627446B2 (en) 1992-08-27
NO178882B (no) 1996-03-18
NO902757L (no) 1990-06-21
EP0391974A1 (en) 1990-10-17
WO1989005650A2 (en) 1989-06-29
GB8729822D0 (en) 1988-02-03
DK153490A (da) 1990-06-22
DK153490D0 (da) 1990-06-22
ATE90567T1 (de) 1993-07-15
EP0391974B1 (en) 1993-06-16
AU3032989A (en) 1989-07-19
DE3881895D1 (de) 1993-07-22
JPH03501085A (ja) 1991-03-14
JPH0664B2 (ja) 1994-01-05
DE3881895T2 (de) 1993-12-02
WO1989005650A3 (en) 1989-07-27
DK175514B1 (da) 2004-11-15
NO902757D0 (no) 1990-06-21

Similar Documents

Publication Publication Date Title
NO178882C (no) Fremgangsmåte for separasjon av vitamin K-avhengige blodkoagulerende faktorer
ES2168387T3 (es) Procedimiento de fraccionamiento de soluciones que contienen sacarosa.
DK0425066T3 (da) Krystallinsk 2-O-alpha-D-glucopyranosyl-L-ascorbinsyre og fremstilling heraf og anvendelser herfor
EP0282042A3 (de) Neue Fusionsproteine und deren Reinigung
ATE216625T1 (de) Methode zur chromatographischen trennung von kationen aus wässrigen proben
ATE200293T1 (de) Verfahren zur chromatographischen reinigung und trennung von nucleinsäuregemischen
MX168497B (es) Ultrafiltracion de flujo tangencial por afinidad
DK0491757T4 (da) Fremgangsmåde til inaktivering af vira i blod og blodprodukter
EP0244834A3 (en) Process for producing a factor v concentrate
DE3361733D1 (en) Process for isolating immunoglobulins from the colostrum
GR3001439T3 (en) Separation agent for optical isomers, process for preparing it and use thereof
ATE88718T1 (de) Verfahren zur reinigung des hepatitis-oberflaechen-antigens und das so erhaltene produkt.
ATE184018T1 (de) Verfahren zur isolation von hoch angereicherten faktoren ix, x und ii vom prothrombin komplex oder menschlichem plasma
HU9200225D0 (en) Complex process containing anti-coagulant ix-factor
DE3169374D1 (en) Compositions able to separate the erythrocytes from the serum or plasma in blood analysis samples, and the method which uses them
DE69434001D1 (de) Reinigung von vitamin-k abhaengigen proteinen durch membrane chromatographie
ATE41740T1 (de) Verfahren zur retardierung von vitamin c und e.
EP0112299A3 (en) Method for superoxidic-dismutasis purification via chromatography by affinity
DE3577809D1 (de) Verfahren zur trennung von wasserstoffisotopen.
GR3015397T3 (en) Separation of anti-metal chelate antibodies.
ES8505380A1 (es) Procedimiento para separar lipoproteinas a partir de un liquido acuoso
DK0846166T3 (da) Fremgangsmåde til thrombinfremstilling
DK1078041T3 (da) Fremgangsmåde til kontinuerlig oprensning og koncentrering af leukocytter fra blod
OA08674A (fr) Procédé de séparation du molybdène par extraction liquide-liquide.
ES442780A1 (es) Un procedimiento y su correspondiente dispostivo para fra- ccionar, en especial partir en dos, asi como para despepitaro despezonar vainas y frutas.